Slides
Page 2
NEXT PHASE OF REBALANCING DECISIVE NIVEA TURNAROUND PLAN LA PRAIRIE IMPROVING WITH SOLID UNDERLYING FUNDAMENTALS MULTI-YEAR DERMA OUTPERFORMANCE CONTINUES RETURN TO PROFITABLE GROWTH STARTING FROM 2028
Page 4
DERMA CONTINUES MULTI-YEAR OUTPERFORMANCE organic sales growth
Page 5
DERMA OUTPERFORMING ACROSS REGIONS organic sales growth, Q2 2026 BRAZIL US FACE CHINA
Page 6
NEXT CHAPTER AQUAPHOR BODY CARE LAUNCH
Page 7
JUL
Page 11
HEALTH CARE STRONG H1 DRIVEN BY INNOVATION
Page 12
organic sales growth, NIVEA incl. Labello EU TRADE CONFLICTS EU SUN SEASON PHASING INNOVATION PHASING & DESTOCKING MIDDLE EAST CONFLICT CORE PORTFOLIO
Page 13
NIVEA REBALANCING PHASE ONE ACCESSIBLE FACE CARE LOCALIZATION WITHIN A FRAME FACE + BODY, DEO
Page 14
GLOBAL EUROPE EMERGING MARKETS 2025 Q3 Q4 2026 Q1 Q2 2025 Q3 Q4 2026 Q1 Q2 2025 Q3 Q4 2026 Q1 Q2
Page 15
FOCUS ON ACCESSIBILITY AND PENETRATION REIGNITE GROWTH THROUGH INNOVATION ACROSS ALL CATEGORIES FULLY LEVERAGE NIVEA’S LOCAL RELEVANCE STEP UP HIGH-IMPACT CONSUMER-FACING INVESTMENTS
Page 16
PREMIUM FACE FACE, BODY, DEO BODY DEO SUN MEN LIP SHOWER FACE
Page 17
PRICE TIER LOW MID HIGH
Page 18
EM APR’26 LAUNCH OIL CONTROL JUL’26 LAUNCH VITAMIN C EU JUL’26 LAUNCH FACE+ RANGE EM Q3’26 LAUNCH COCOA INDIA JUN’26 LAUNCH SOFT GEL ASEAN AUG’26 RELAUNCH EVEN TONE EM Q1-Q2 ‘26 LAUNCH SKIN GLOW EU Q1 ‘27 LAUNCH CLASSICS RANGE
Page 19
H2 2025 H2 2026 + €100M
Page 20
organic sales growth, NIVEA incl. Labello
Page 22
SEGMENTS KEY FIGURES EBIT and EBIT margin excluding special factors (IN € MILLION) H1 2025 H1 2026 CHANGE NOMINAL ORGANIC CONSUMER SALES 4,330 4,113 -5.0% -4.0% EBIT 691 632 EBIT MARGIN 16.0% 15.4% TESA SALES 858 839 -2.1% -0.9% EBIT 145 136 EBIT MARGIN 16.9% 16.2%
Page 24
H1 2025 0.1 PRICE -0.5 COST 0.0 MIX -0.6 FX H1 2026 62.0 61.0 -100 bps Gross profit as a percentage of sales
Page 25
GROUP INCOME STATEMENT (IN € MILLION) H1 2025 ORGANIC GROWTH/ % OF SALES H1 2026 ORGANIC GROWTH/ % OF SALES SALES 5,188 2.1% 4,952 -3.5% COST OF GOODS SOLD -2,108 - -2,064 - GROSS PROFIT 3,080 59.4% 2,888 58.3% MARKETING AND SELLING EXPENSES -1,772 34.2% -1,724 34.8% RESEARCH AND DEVELOPMENT EXPENSES -184 3.6% -188 3.8% GENERAL AND ADMINISTRATIVE EXPENSES -317 6.1% -275 5.6% OTHER OPERATING RESULT 29 - 67 - OPERATING RESULTS (EBIT, EXCL. SPECIAL FACTORS) 836 16.1% 768 15.5% SPECIAL FACTORS -20 - -8 - OPERATING RESULT (EBIT) 816 - 760 - FINANCIAL RESULT 1 - 28 - PROFIT BEFORE TAX 817 - 788 - INCOME TAX -256 - -230 - PROFIT AFTER TAX 561 10.8% 558 11.3% EPS (IN €) 2.47 2.52
Page 27
CONTINUED SLOW MARKET CRISIS IN THE MIDDLE EAST NIVEA TURNAROUND CHALLENGING H2 2026 AHEAD
Page 28
2026 CONSUMER EBIT HEADWINDS EBIT IMPACT COST / FX MIX CONSUMER FACING INVESTMENTS EFFICIENCY MEASURES EBIT MARGIN ~ -250 bps PRICE
Page 29
GUIDANCE 2026 2025 data for reference: Consumer EBIT margin* 13.6% tesa EBIT margin* 16.1% Group EBIT margin* 14.0% CONSUMER Low-single digit organic net sales decline EBIT margin* of at least 11.0% TESA Net sales flat to slightly growing organically EBIT margin* slightly below previous year GROUP Low-single digit organic net sales decline EBIT margin* of at least 11.8%
Page 30
NET SALES GROWTH ABOVE MARKET MIDTERM OUTLOOK PROFITABLE GROWTH IMPROVED CASH CONVERSION
Page 31
MIDTERM OUTLOOK IMPROVED CASH RETURN TO SHAREHOLDERS GROWTH VIA M&A